Safety and Incidence of Side Effects in a Cohort of Postmenopausal Women Prescribed Ospemifene Relative to Patients Diagnosed with but not Treated for Vulvar and Vaginal Atrophy (VVA) and Patients on Selective Oestrogen Receptor Modulators (SERMs) for Oestrogen-deficiency Conditions or Breast Cancer Prevention – A Post-Authorisation Safety Study

11/02/2015
17/05/2021
EU PAS number:
EUPAS8585
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data source(s)

Data source(s), other

MarketScan United States

Data sources (types)

Administrative healthcare records (e.g., claims)
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No